Sun, 17 Mar 2013 04:57:12 GMT

Boston Globe
Biogen Idec readies its next move

Boston Globe

The company also pulled a powerful multiple sclerosis treatment from the market, relaunched it, and turned the drug into a blockbuster that is ringing up annual sales of more than $1 billion. But the most climactic chapter in the company's quest for ...